iRadimed
IRMD
97 hedge funds and large institutions have $231M invested in iRadimed in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 8 closing their positions.
300% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 8
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
45% more capital invested
Capital invested by funds: $159M → $231M (+$72.1M)
31% more funds holding
Funds holding: 74 → 97 (+23)
22% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 23
2.15% more ownership
Funds ownership: 38.36% → 40.51% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$2.81M |
| 2 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$2.3M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$1.72M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.69M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.87M |
| 2 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
-$2.13M |
| 3 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$2.09M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$1.46M |
| 5 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$1.25M |
IRMD Hedge Fund Activity: Q4 2021 in Review
97 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2021, worth a combined $231M — up 45% from $159M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new IRMD positions and 8 closed out — a net gain of 24 holders — while 28 added to existing stakes and 23 trimmed.
The largest buyer was Calamos Advisors, opening a new position worth an estimated $2.81M. The largest seller was Vanguard Group, cutting an estimated $3.87M.
- 97 institutional investors held iRadimed (IRMD) as of Q4 2021, up from 74 in Q3 2021.
- Funds reported $231M of iRadimed stock for Q4 2021, up 45% quarter-over-quarter.
- 32 funds opened new iRadimed positions in Q4 2021 and 8 closed out, a net change of +24 holders.
- The largest iRadimed buyer in Q4 2021 was Calamos Advisors, an estimated $2.81M added.
- The largest iRadimed seller in Q4 2021 was Vanguard Group, an estimated $3.87M sold.
Based on aggregated 13F filings for Q4 2021.